Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jury Still Out On EVAR Versus Open Surgery For Abdominal Aortic Aneurysm

This article was originally published in The Gray Sheet

Executive Summary

Proponents of endovascular repair for abdominal aortic aneurysm (AAA) have yet to prove that the less invasive procedure is any better than open surgical repair, although mixed study results signal that the jury is still out

You may also be interested in...



NEJM Study Touts Longer Lasting Survival Benefit Of Endovascular AAA Repair

The relative long-term benefits of endovascular repair versus invasive surgery for abdominal aortic aneurysms (AAA) may be greater than previously thought, according a study published Jan. 31 in the New England Journal of Medicine

NEJM Study Touts Longer Lasting Survival Benefit Of Endovascular AAA Repair

The relative long-term benefits of endovascular repair versus invasive surgery for abdominal aortic aneurysms (AAA) may be greater than previously thought, according a study published Jan. 31 in the New England Journal of Medicine

Carotid Stent, AAA Market Entry: Boston Scientific Moves On Earn-Outs

Boston Scientific intends to acquire carotid stent manufacturer EndoTex by year-end, following an anticipated FDA approval of NexStent

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel